Shabnum Patel

4PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 08, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.

Yi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton

|Sep 13, 2022
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy.

Zinaida Good, Jay Y Spiegel, Bita Sahaf

|Jul 27, 2021
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.

Jay Y Spiegel, Shabnum Patel, Lori Muffly

|May 14, 2021
A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies.

Chase D McCann, Christiaan H van Dorp, Ali Danesh

Pageof 1

Frequent Collaborators

3 joint publications

David B Miklos

3 joint publications

Lori Muffly

2 joint publications

Juliana Craig

2 joint publications

Crystal L Mackall